The Beddit Sleep Monitor tracks patients’ sleep accurately without any disturbing wearable sensors. Patients can sleep directly on the sensor and it will measure heart rate, respiration, sleep cycles and sleep time. Beddit Sleep Tracker is based on ballistocardiography (BCG), a measure of ballistic forces on the heart. During …
Read More »Interview with NuSirt CEO Joe Cook, Jr: Improving Metformin Treatment, Part 2
This week, we continue our exclusive short interview series with NuSirt CEO, JC, in which he talks about some of the groundbreaking work his company is doing to increase the effectiveness of metformin. Steve Freed, Publisher, Diabetes in Control: What actually brought you to taking this compound and combining it …
Read More »Interview with NuSirt CEO Joe Cook, Jr: Improving Metformin Treatment, Part 1
This week, we’re taking a break from our regularly featured section on avoiding medication mistakes to bring you this exclusive interview series with NuSirt CEO, JC, in which he talks about some of the groundbreaking work his company is doing to increase the effectiveness of metformin. Steve Freed, Publisher, Diabetes …
Read More »Diabetes Mellitus 101 for Cardiologists, Part 4
In this week’s Homerun Slides, Dr. Stanley Schwartz tackles the topic of the best blood glucose levels for a hospital setting. He presents data from several different studies including First DIGAMI and the Portland Diabetic Project, as well as several others in his discussion of this important subject… To download …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #16: Diabetic Neuropathy
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Symptoms, signs and classification Diabetes is one of the most common causes of peripheral neuropathy, a term that encompasses a heterogeneous group of disorders (Figure 17.1). In population-based surveys, up to one-third of patients with diabetes have evidence of peripheral neuropathy but …
Read More »FDA Approves Xigduo XR, a New Dapagliflozin-Metformin Combination
The once-daily oral tablet is the first in the U.S. to combine the SGLT-2 inhibitor dapagliflozin with the biguanide extended-release (XR) metformin hydrochloride.. The US Food and Drug Administration (FDA) has approved a once-daily combination of dapagliflozin and metformin hydrochloride extended-release (Xigduo XR, AstraZeneca) for the treatment of adults with …
Read More »Dietary Magnesium Intake’s Role in Decreasing Metabolic Syndrome
The overall risk of metabolic syndrome decreased with every 100 mg per day increment in magnesium intake…. Previous studies have shown conflicting accounts of how beneficial dietary magnesium intake is in decreasing the risk of metabolic syndrome. The purpose of this meta-analysis was to determine the association between metabolic syndrome …
Read More »DPP-4 Inhibitors in Combination with Insulin Therapy for Type 2 Diabetes Patients
The addition of a DPP-4 inhibitor decreased HbA1C while not requiring an increase in insulin, and subjects remained weight neutral without experiencing an increase in hypoglycemic events… Currently approved dipeptidyl peptidase-4 (DPP-4) inhibitors include alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin. DPP-4 inhibitors work by enhancing glucose dependent insulin secretion and …
Read More »Stress Could Be Contributor to Progression of Type 2 Diabetes
Type 2 diabetes patients were more likely to have lower stress reactivity and impaired stress recovery when compared to healthy subjects… Stress-related factors are thought to play a role in the development of type 2 diabetes. Such factors have an impact on metabolic, cardiovascular and inflammatory regulation. Previous studies have …
Read More »The Impact of Physical Activity on Young Type 1 Diabetes Patients
Physical activity intervention had a positive impact on reducing HbA1c, BMI and total cholesterol but insulin dosage did not change in the study… Due to the increased risk of cardiovascular disease in type 1 diabetes patients, physical activity is advised. This recommendation is used in combination with insulin therapy and …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.